Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "Progeria"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Condition: Progeria
Intervention: Drug: Lonafarnib, Zoledronic Acid, and Pravastatin
2 Completed Clinical Studies of Progeria
Condition: Progeria
Intervention:
3 Recruiting Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Condition: Progeria
Intervention: Drug: Everolimus and lonafarnib
4 Completed A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Condition: Progeria
Interventions: Drug: Lonafarnib;   Drug: Zoledronic Acid;   Drug: Pravastatin
5 Unknown  Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
Conditions: Progeria;   Hutchinson-Gilford Syndrome
Intervention: Drug: Lonafarnib
6 Completed Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid
Condition: Hutchinson-Gilford Progeria Syndrome
Intervention: Drug: Zoledronic acid, pravastatin

Study has passed its completion date and status has not been verified in more than two years.